Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03040141 · ClinicalTrials.gov registry record · Phase 2
Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A
A Phase 2 study of Influenza a, sponsored by Visterra.
- Completed
- Registry status
- Phase 2
- Development phase
- 89
- Enrollment target
- 20
- Study locations
NCT03040141 is a Phase 2 study of Influenza a that has completed, run by Visterra. The registered enrollment target is 89 participants, below the 2,745-participant average among 10 other Influenza a trials with a reported enrollment target (97% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT03040141, a Phase 2 study of Influenza a, has completed, sponsored by Visterra.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 89 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is to compare the efficacy and safety of VIS410 in combination with oseltamivir vs oseltamivir alone in severely ill subjects with influenza A infection requiring oxygen support.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Low dose of VIS410
- DRUG High dose of VIS410
Study Locations (20)
Pennsylvania
- Visterra - Allentown
- Visterra - Philadelphia
- Visterra - York
Georgia
- Visterra - Atlanta
- Visterra - Decatur
New York
- Visterra - Albany
- Visterra - Syracuse
North Carolina
- Visterra - Durham
- Visterra - Greensboro
Ohio
- Visterra - Cleveland
- Visterra - Columbus
Arizona
- Visterra - Tucson
California
- Visterra - Stanford
Florida
- Visterra - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2018-01-03 |
| Est. Completion | 2018-11-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03040141
The ClinicalTrials.gov registry entry for NCT03040141 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,745-participant average among 10 other Influenza a trials with a reported enrollment target (97% lower). The listed sponsor is Visterra, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Influenza a appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT03040141 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Pennsylvania, Georgia, New York.
Frequently Asked Questions
What is clinical trial NCT03040141 about?
NCT03040141 is a clinical study titled "Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A". This study is to compare the efficacy and safety of VIS410 in combination with oseltamivir vs oseltamivir alone in severely ill subjects with influenza A infection requiring oxygen support.
What is the current status of trial NCT03040141?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 89 participants. The study started on 2018-01-03. Estimated completion is 2018-11-22.
What conditions does trial NCT03040141 study?
This clinical trial studies the following conditions: Influenza a.
What interventions are being tested in trial NCT03040141?
The interventions under investigation include: Placebo (DRUG), Low dose of VIS410 (DRUG), High dose of VIS410 (DRUG).
Who is sponsoring clinical trial NCT03040141?
This trial is sponsored by Visterra, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03040141 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza a
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients
RECRUITING · NA
-
A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)
ACTIVE NOT RECRUITING · Phase 1
-
Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines
COMPLETED · Phase 1
-
Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections
COMPLETED
-
Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza
COMPLETED · Phase 3
-
Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.